Transplantation And Cellular Therapy SCIE
國際簡稱：BIOL BLOOD MARROW TR 參考譯名：移植和細胞治療
主要研究方向：Medicine-Hematology 非預警期刊 審稿周期：
《移植和細胞治療》(Transplantation And Cellular Therapy)是一本由Elsevier出版的以Medicine-Hematology為研究特色的國際期刊，發(fā)表該領域相關的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領域相關理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領域科學信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預警名單。
Transplantation and Cellular Therapy, the official publication of the American Society for Transplantation and Cellular Therapy , focuses on current technology and knowledge in the interdisciplinary field of hematopoetic stem cell transplantation and the growing field of transplant and non-transplant cellular immunotherapies. The Journal publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.This magazine is committed to promoting the development of scientific research and clinical applications in the fields of cell therapy and transplantation, providing a platform for scientists, doctors, and researchers engaged in related research worldwide to exchange and share the latest research results. As a professional journal focusing on the fields of cell therapy and transplantation, it provides a platform for researchers to showcase their research results and exchange academic views, which is of great significance for promoting the development of related fields.
Transplantation And Cellular Therapy期刊信息
- ISSN：2666-6375
- 出版語言：None
- 是否OA：開放
- E-ISSN：2666-6367
- 出版地區(qū)：UNITED STATES
- 是否預警：否
- 出版商：Elsevier
- 開源占比：0.1987
- Gold OA文章占比：76.35%
- OA被引用占比：
- 出版國人文章占比：0
- 出版撤稿占比：
- 研究類文章占比：94.58%
Transplantation And Cellular Therapy CiteScore評價數(shù)據(jù)（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||||||||||||||||||
| 7 | 1.602 | 1.113 |
|
名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
Transplantation And Cellular Therapy中科院評價數(shù)據(jù)
中科院 2023年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 3區(qū) | HEMATOLOGY 血液學 IMMUNOLOGY 免疫學 TRANSPLANTATION 移植 | 3區(qū) 3區(qū) 3區(qū) |
中科院 2022年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | HEMATOLOGY 血液學 TRANSPLANTATION 移植 IMMUNOLOGY 免疫學 | 2區(qū) 2區(qū) 3區(qū) |
Transplantation And Cellular Therapy JCR評價數(shù)據(jù)（2023-2024年最新版）
| 按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：HEMATOLOGY | SCIE | Q2 | 25 / 97 |
74.7% |
| 學科：IMMUNOLOGY | SCIE | Q2 | 86 / 181 |
52.8% |
| 學科：TRANSPLANTATION | SCIE | Q1 | 7 / 31 |
79% |
| 按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：HEMATOLOGY | SCIE | Q1 | 24 / 97 |
75.77% |
| 學科：IMMUNOLOGY | SCIE | Q2 | 48 / 181 |
73.76% |
| 學科：TRANSPLANTATION | SCIE | Q2 | 8 / 31 |
75.81% |
Transplantation And Cellular Therapy歷年數(shù)據(jù)統(tǒng)計
影響因子
中科院分區(qū)
Transplantation And Cellular Therapy中國學者發(fā)文選摘
-
1、Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China
Author: Gong, Susu; Chen, Cong; Chen, Keke; Yang, Rui; Wang, Leyuan; Yang, Kaitai; Hu, Jian; Nie, Lin; Su, Tao; Xu, Yajing; He, Xianglin; Yang, Liangchun; Xiao, Hong; Fu, Bin
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 480-480000000. DOI: 10.1016/j.jtct.2022.10.006
-
2、Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients
Author: Deng, Rui-Xin; Zhu, Xiao-Lu; Zhang, Ao-Bei; He, Yun; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting -Ting; Chen, Yu -Hong; Chang, Ying-Jun; Xu, Lan -Ping; Huang, Xiao-Jun; Zhang, Xiao-Hui
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 1, pp. 570-570000000000. DOI: 10.1016/j.jtct.2022.10.007
-
3、Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement
Author: Miao, Fujia; Ren, Guisheng; Guo, Jinzhou; Zhao, Liang; Xu, Weiwei; Huang, Xianghua
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 2, pp. 1100-11000000000. DOI: 10.1016/j.jtct.2022.10.021
-
4、Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy
Author: Li, Zhihui; An, Na; Yang, Keyan; Meng, Fanqiao; Xu, Teng; Peng, Xiaojuan; Wen, Xiaopei; Li, Jing; Song, Yanzhi; Yang, Rui; Wu, Tong
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 3, pp. 167-173. DOI: 10.1016/j.jtct.2022.11.013
-
5、A Prognostic Model Based on Clinical Biomarkers for Heart Failure in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
Author: Zhang, Ao-Bei; Wang, Chen-Cong; Zhao, Peng; Tong, Ke-Ting; He, Yun; Zhu, Xiao-Lu; Fu, Hai-Xia; Wang, Feng-Rong; Mo, Xiao-Dong; Wang, Yu; Zhao, Xiang-Yu; Zhang, Yuan-Yuan; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chen-Hua; Wang, Jing-Zhi; Han, Ting-Ting; Sun, Yu-Qian; Chen, Yu-Hong; Chang, Ying-Jun; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun; Zhang, Xiao-Hui
Journal: TRANSPLANTATION AND CELLULAR THERAPY. 2023; Vol. 29, Issue 4, pp. -. DOI: 10.1016/j.jtct.2022.12.008
Transplantation And Cellular Therapy同類期刊
-
公共衛(wèi)生前沿
Frontiers In Public Health
中科院 3區(qū) JCR Q2
-
藥理學前沿
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
-
生物醫(yī)學與藥物治療
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
-
探索腫瘤學
Discover Oncology
中科院 4區(qū) JCR Q2
-
Bmc精神病學
Bmc Psychiatry
中科院 2區(qū) JCR Q2
-
Bmc神經(jīng)病學
Bmc Neurology
中科院 3區(qū) JCR Q3
-
材料化學雜志 B
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
-
美康
Medcomm
中科院 3區(qū) JCR Q1
免責聲明